International Conference on

Oncology

Oncology 2022

Theme: Amalgamation of innovations in cancer treatment & Challenges during COVID-19

We welcome all the dynamic scholars from all over globe to attend the International Conference on Oncology  scheduled on  April 20-21, 2022 in Miami, USA. 

This important educational activity will provide guidance to front-line and oncology clinicians, nurses, nurse practitioners, physician assistants and pharmacists with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on myeloma, gynecological malignancies, hematologic malignancies, sarcoma, bladder cancer and GI malignancies.

The conference features a comprehensive review of new drugs approved along with their mechanism of action, next generation CAR T-cell therapies and a keynote lecture outlining advances in immunotherapy. Next generation studies will also be addressed and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.

Session 1. Oncology
 
The study of cancer is a much known firm with emerging inventions patenting in order to cure as well as prevent people from the risk of cancer. Since now, more than 120 types of cancer have been reported. Apart from more common cancers, rare cancers like Ataxia-Telangiectasia, Familial GIST are also affecting peoples in various parts of the world.
 
Benign and Malignant
Metastasis
Curative and Palliative treatment
 
 
 
In the elimination phase, the immune response leads to destruction of tumor cells and therefore to tumor suppression. However, some tumor cells may gain more mutations, change their characteristics and evade the immune system. These cells might enter the equilibrium phase, in which the immune system doesn’t recognise all tumor cells, but at the same time the tumor doesn’t grow. 
 
 
 
As per the UICC report, around 8 million people are dying worldwide because of cancer. One in three of us will develop cancer at some time in our lives, and one in four will die of it. As we see locally, cancer is now the most common cause of premature death in Scotland. Each year, around 29,000 people will have a new cancer diagnosed and at any one time around 150,000 people may be affected. This number will be increasing towards the end of the century due to the increase in the elderly population.
 
Major public health problem
Ranks II in causing death in US
Prevented by maintaining healthy lifestyle
 
 
Session 4. Women Cancer
 
Some of the cancers that most often affect women are breast, colorectal, endometrial, lung, cervical, skin, and ovarian cancers. Knowing about these cancers and what you can do to help prevent them or find them early (when they are small, haven't spread, and might be easier to treat) may help save your life.
 
Breast Cancer
Endometrial Cancer
Cervical Cancer
Skin Cancer
Ovarian Cancer
 
 
Session 5. Medical Oncology
 
Medical oncology is a method of treating cancer by using principles of Chemotherapy, Immunotherapy, Hormonal therapy and targeted therapy in a sufficient way to treat cancer. In order to get effective positive outcomes, medical oncology is used in conjunction with surgical oncology and radiation oncology. Oncology conference 2021 will give you the ideas about developing these techniques which could melt down the certain hurdles in diagnostics and treatment.
 
Radiation Oncologists
Radiation therapists
Medical Radiation Physicists
Dosimetrists
 
 
 
Children with cancer are at risk for developing various cognitive or learning problems. These difficulties may be related to brain injury stemming from the cancer itself, such as a brain tumor or central nervous system metastasis or from side effects of cancer treatments such as chemotherapy and radiation therapy. 
 
Leukamia
Brain Tumours
Lymphomas
 
Session 7. Radiation Oncology
 
Most common method includes the identification of biological markers in blood and biopsy. Besides, the imaging techniques like CT, MRI, X-rays, Scintigraphy, Nuclear medicine techniques are in wide usage for diagnosing and treating cancer. In several cases, surgery is also done to treat cancers. Several molecular targeting agents are also approved in past ten years for the treatment of cancer by US FDA.
 
Immuno therapeutics
Molecular targeted therapy & diagnostics
Genomic prediction of therapeutic efficacy
Proof-of-mechanism pharmacodynamics
 
 
 
Cancer research is research into cancer to identify causes and develop strategies for prevention, diagnosis, treatment, and cure.Cancer research ranges from epidemiology, molecular bioscience to the performance of clinical trials to evaluate and compare applications of the various cancer treatments. These applications include surgery, radiation therapy, chemotherapy, hormone therapy and immunotherapy and combined treatment modalities such as chemo-radiotherapy.
 
 
 
 
Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. The overall drug consumption and side-effects may be lowered significantly by depositing the active agent in the morbid region only and in no higher dose than needed. Targeted drug delivery is intended to reduce the side effects of drugs with concomitant decreases in consumption and treatment expenses.
 
 
 
 
Biotechnology played and also will continue to play a massive role in oncology ranging from immune-oncology, monoclonal antibodies, CAR-T and also everything in between. There is a main limitation in traditional way is that the lack of specificity which can be achieved by monoclonal antibodies. These can act well than chemical drugs in blocking signal pathways as well as invoking immune response against the tumour. 
 
Monoclonal antibodies
Cell Therapy
Gene Therapy
 
 
 
 
Session 11. Molecular Oncology
 
Molecular Oncology is the study about the combination of oncology and medicinal chemistry. It involves the evaluation of chemistry of cancers and tumours at molecular scale. The researchers in this field use diverse techniques to study biological and clinical phenotypes.
 
Molecularly targeted therapies
Tumour imaging
In vitro & In vivo functional studies
 
 
 
 
Oncology Scientists in all parts of the world are working with the intention of development of drugs for the new cancers and also for existing ones. These drugs are developed through many phases by means of clinical studies. The drug is developed mainly in the form of agonists or antagonists.
 
Drug development
Pre-clinical Research
Clinical Research
FDA Approval 
 
 

 

Global Data Estimates that the total oncology market will be worth approximately 92 billion in 2020 to $84.38 billion in 2021 at a compound annual growth rate (CAGR) of   4.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $112.14 billion in 2025 at a CAGR of 7%.

The oncology drugs market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, brain tumor, and other different cancer types.

 

Universities associated with Oncology worldwide

  • Drexel University, Philadelphia.
  • Georgetown University, Washington DC 
  • Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, New York,
  • Oregon Health & Science University, Portland,
  • Stanford University, Stanford.
  • The University of Texas Health Science Center at Houston
  • University of Chicago, Chicago.
  • Duke University, Durham
  • Johns Hopkins University, Baltimore

 

For the past 25 years Oncology has kept pace with the progression of the oncology field and has offered an interpretation of literature which appeals to both the academician and the practicing "in-the-trenches" community oncologist.
 
Editorial features such as Practice & Policy, explore the changing times in the healthcare landscape in such areas as FDA regulations, Medicare & Medicaid policy, and the impact of health care reform. Another feature is Integrative Oncology which covers alternative herbal treatments, uses, research, adverse reactions and interactions.
 
ONCOLOGY serves as a strong resource and forum for the cancer care clinician and generates a strong sense of community among its readers.
Meetings International is announcing Young Scientist Awards through International Conference on Oncology (Oncology 2021) which is scheduled at Maimi, USA on April 20-21, 2022. This Oncology 2022 focuses on “Exploring Innovations and Advancements in the Oncology”.
 
Oncology 2022 and upcoming conferences will recognise participants who have significantly added value to the scientific community of Oncology and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
 
Oncology 2022 operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.
 
Universities associated with Oncology worldwide
 
Drexel University, Philadelphia.
Georgetown University, Washington DC 
Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, New York,
Oregon Health & Science University, Portland,
Stanford University, Stanford.
The University of Texas Health Science Center at Houston
University of Chicago, Chicago.
Duke University, Durham
Johns Hopkins University, Baltimore
Hospitals associated with Oncology
 
Oceania Oncology Maroochydore, QLD, Australia
MacArthur Cancer Service, Sydney, NSW, Australia
James Cancer Hospital & Solove Research Institute Columbus, OH, United States
Peter Maccallum Health Centre Melbourne, VIC, Australia
University of Washington Medical Center/Seattle Cancer Care Alliance Seattle, WA, United States
Oslo Comprehensive Cancer Centre Oslo, Norway
Georgetown Lombardi Comprehensive Cancer Center Northwest, Washington, D.C., United States
UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC, United States
Vall D’Hebron Institute of Oncology Barcelona, Spain
Epworth Radiation Oncology Melbourne, VIC, Australia
Institute Gustavo Roussy Villejuif, France
Hong Kong Adventist Hospital Hong Kong, China
Calvary Mater Newcastle Hospital Waratah, NSW, Australia
Townsville Cancer Centre Douglas, QLD, Australia
Genesis Cancer Care Sydney, NSW, Australia
Apollo Hospitals Chennai, India (also Bangladesh, Kuwait, & Qatar)
Industries associated with Oncology
 
Roche
Celgene
Pfizer
Bristol-Myers Squibb
Novartis
AstraZeneca
Merck & Co

Meetings International & Oncology 2022 offer several awards given to recognize outstanding scholarly contributions to the field of international studies. These awards have different committees, nominating procedures and submission deadlines. They recognize 1.Best Organising Committee Member Award; 2.Excellent Keynote talks Award; 3.Outstanding Speaker Award; 4.Outstanding Young Researchers’ Forum Award; 5.Best Poster Award.

Best Organizing Committee Member Award: Oncology 2022 will honour the individual who has demonstrated exemplary support and guidance throughout the conference. Recipients of the award are considered to have advanced in the field of Oncology through research or service.

Excellent Keynote Speaker Award: Opening remarks or presentation at Oncology 2022 sets the tone or theme of the event and motivates attendees. Excellent Keynote Award will be given to the speaker who has made significant contributions to the field of Oncology but also made a difference with their presence during the Oncology 2022.

Outstanding Speaker Award: Oncology 2022 perceives the individuals who have made significant and imaginative walks in education system. This honour perceives advancement in instructing methodologies and strategies just as in conveying oral presentation in conference. This honour explicitly centres on the uniqueness and creativity that expands member’s interests.

Outstanding Young Researchers’ Forum Award: This award recognizes individuals in the early stages of their careers that have already made outstanding research, teaching, and/or service contributions to the field of information systems.

Best Poster Award: This award recognizes individuals from poster presenters who have display their outstanding research and findings for an innovative future. Recipients of the award are considered to be the Best Poster Presenter of the conference.

 

Criteria:

All presented abstracts will automatically be considered for the Award.

All the presentation will be evaluated in the conference venue

All the awards will be selected by the judges of the award category

The winners will be formally announced during the closing ceremony.

The winners of the Poster Award will receive award certificate.

The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

All submissions must be in English.

The topic must fit into scientific sessions of the conference

Each individual participant is allowed to submit maximum 2 papers

Abstract must be submitted online as per the given abstract template

Abstracts must be written in Times New Roman and font size will be 12

Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference

Each poster should be approximately 1x1 M long. The title, contents and the author’s information should be clearly visible from a distance of 1-2 feet.

  • Oncology
  • Tumour Immunology and Immunotherapy
  • Oncology diagnostics & therapeutics
  • Women Cancer
  • Medical Oncology
  • Paediatric Oncology
  • Radiation Oncology
  • Advances in Cancer Research and Treatment
  • Cancer Nanotechnology
  • Cancer Biotechnology
  • Molecular Oncology
  • Cancer Prevention Vaccines

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner